Physician profile
Ali Borhan
NPI 1518963024
$41,880.47
in general payments reported to CMS, 2019-2025
59 companies · $6,989 in 2025
The $6,989 reported for 2025 was more than what 92% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,713 · 2020: $12K · 2021: $1,357 · 2022: $2,469 · 2023: $3,197 · 2024: $8,845 · 2025: $6,989.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Food and Beverage: $8,594 · Travel and Lodging: $36.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,400.00 |
| Food and Beverage | $8,594.39 |
| Travel and Lodging | $36.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,717.70 | 2019-2023 | Da Vinci Surgical System |
| Ethicon INC. | $10,530.94 | 2021-2025 | |
| Abbott Laboratories | $5,340.48 | 2019-2025 | Aveir, Assurity, Gallant |
| Boston Scientific Corporation | $2,283.26 | 2019-2024 | Spaceoar Vue System - 10ml, Ams 700 Cxr Rte Kit, Lithovue |
| Coloplast Corp | $1,286.50 | 2019-2024 | Speedicath, Porges Coloplast, Vortek Hydro |
| Abbvie INC. | $900.68 | 2019-2025 | Avycaz, Lupron Depot, Botox |
| Calyxo, INC. | $704.14 | 2024-2025 | Cvac Aspiration System |
| Pfizer INC. | $632.44 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $582.49 | 2019-2021 | |
| Astellas Pharma US INC | $503.94 | 2019-2025 | Xtandi, Myrbetriq |
| Procept Biorobotics Corporation | $493.34 | 2022-2023 | Aquabeam Robotic System |
| Neotract INC. | $379.14 | 2019 | |
| Medtronic, INC. | $309.68 | 2021-2024 | Ligasure, Interstim |
| Teleflex LLC | $306.69 | 2022-2025 | Barrigel, Urolift |
| Urogen Pharma, INC. | $274.92 | 2020-2025 | Jelmyto |
Show all 59 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Borhan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.